Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1118-1126

  Dheda, K ^a,b,c,d   Van Zyl Smit, R N ^a,b   Sechi, L A ^e   Badri, M ^a,b   Meldau, R ^a,b   Meldau, S ^a,b   Symons, G ^a,b   Semple, P L ^a,b   Maredza, A ^a,b   Dawson, R ^a,b   Wainwright, H ^c   Whitelaw, A ^c   Vallie, Y ^a,b   Raubenheimer, P ^a,b   Bateman, E D ^a,b   Zumla, A ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

Diagnosis; Diagnostic accuracy; Human; Interferon ; Pleural effusion; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUBERCULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PLEURA EFFUSION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; T LYMPHOCYTE; TUBERCULOUS PLEURISY;

ADULT; AGED; CHEMISTRY, CLINICAL; COHORT STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PULMONARY MEDICINE; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULOSIS, PLEURAL;

EID: 71049122455     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00005309     Document Type: Article

References (32)

1. Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131: 880-889.
2. Sinzobahamvya N, Bhakta HP. Pleural exudate in a tropical hospital. Eur Respir J 1989; 2: 145-148.
3. Trajman A, Pai M, Dheda K, et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J 2008; 31: 1098-1106.
4. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon-γ measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003; 7: 777-786. (Pubitemid 36987942)
5. Pokkali S, Das SD, Logamurthy R. Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 2008; 41: 307-314. (Pubitemid 351308157)
6. Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-γ in tuberculous pleurisy: a metaanalysis. Chest 2007; 131: 1133-1141. (Pubitemid 46608717)
7. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354. (Pubitemid 351650594)
8. Pai M, Dheda K, Cunningham J, et al. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438. (Pubitemid 46779096)
9. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
10. Wilkinson KA, Wilkinson RJ, Pathan A, et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005; 40: 184-187. (Pubitemid 40053478)
11. Jafari C, Ernst M, Strassburg A, et al. Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J 2008; 31: 261-265.
12. Jafari C, Ernst M, Kalsdorf B, et al. Rapid diagnosis of smearnegative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006; 174: 1048-1054. (Pubitemid 44684455)
13. Losi M, Bossink A, Codecasa L, et al. Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007; 30: 1173-1179. (Pubitemid 351194766)
14. Ariga H, Kawabe Y, Nagai H, et al. Diagnosis of active tuberculous serositis by antigen-specific interferon-γ response of cavity fluid cells. Clin Infect Dis 2007; 45: 1559-1567.
15. Baba K, Sornes S, Hoosen AA, et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERONTB-Gold interferon-γ assay. BMC Infect Dis 2008; 8: 35.
16. Chegou NN, Walzl G, Bolliger CT, et al. Evaluation of adapted whole-blood interferon-γ release assays for the diagnosis of pleural tuberculosis. Respiration 2008; 76: 131-138.
17. Joshi R, Pai M. Can pleural tuberculosis be diagnosed using interferon-γ release assays? Respiration 2008; 76: 128-130.
18. Hougardy JM, Schepers K, Place S, et al. Heparin-binding-hemagglutinin- induced IFN-γ release as a diagnostic tool for latent tuberculosis. PLoS One 2007; 2: e926.
19. Locht C, Hougardy JM, Rouanet C, et al. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb) 2006; 86: 303-309.
20. Delogu G, Bua A, Pusceddu C, et al. Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis. FEMS Microbiol Lett 2004; 239: 33-39. (Pubitemid 39296713)
21. Trajman A, Luiz RR. McNemar Chi-squared test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 2008; 68: 77-80. (Pubitemid 351161511)
22. Moons KG, Harrell FE, Steyerberg EW. Should scoring rules be based on odds ratios or regression coefficients? J Clin Epidemiol 2002; 55: 1054-1055.
23. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003; 49: 1-6. (Pubitemid 36078546)
24. Dheda K, Van-Zyl Smit RN, Sechi LA, et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 2009; 4: e4689.
25. Neves DD, Dias RM, Cunha AJ. Predictive model for the diagnosis of tuberculous pleural effusion. Braz J Infect Dis 2007; 11: 83-88. (Pubitemid 47024101)
26. Porcel JM, Vives M. Differentiating tuberculous from malignant pleural effusions: a scoring model. Med Sci Monit 2003; 9: CR175-CR180. (Pubitemid 36713439)
27. Temmerman S, Pethe K, Parra M, et al. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med 2004; 10: 935-941. (Pubitemid 39273734)
28. Delogu G, Sanguinetti M, Posteraro B, et al. The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice. Infect Immun 2006; 74: 3006-3011. (Pubitemid 43673012)
29. Zanetti S, Bua A, Delogu G, et al. Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin. Clin Diagn Lab Immunol 2005; 12: 1135-1138. (Pubitemid 41324551)
30. Yang CS, Lee JS, Lee HM, et al. Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respir Med 2008; 102: 280-286.
31. Chen X, Zhou B, Li M, et al. CD4+/CD25+/FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007; 123: 50-59.
32. Hougardy JM, Place S, Hildebrand M, et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007; 176: 409-416. (Pubitemid 47267476)